Patients with portal hypertension and cirrhosis have a high incidence of pulmonary hypertension: 0.7% versus 0.1% in 17,901 autopsies 1 and even as high as 2% in patients with portal hypertension and without evidence of cardiac or pulmonary disorders 2 . Primary pulmonary hypertension in liver transplantation (LTX) recipients is associated with high mortality and morbidity 3-8 and their selection and perioperative management remain a challenge to the LTX team. We present a successful orthotopic LTX in a patient with preoperatively undiagnosed severe pulmonary hypertension.
Patients with portal hypertension and cirrhosis have a high incidence of pulmonary hypertension: 0.7% versus 0.1% in 17,901 autopsies 1 and even as high as 2% in patients with portal hypertension and without evidence of cardiac or pulmonary disorders 2 . Primary pulmonary hypertension in liver transplantation (LTX) recipients is associated with high mortality and morbidity [3] [4] [5] [6] [7] [8] and their selection and perioperative management remain a challenge to the LTX team. We present a successful orthotopic LTX in a patient with preoperatively undiagnosed severe pulmonary hypertension.
CASE REPORT
A 55-year-old male (weight 77 kg, height 1.8 m) with primary sclerosing cholangitis and hepatitis B was referred as an LTX candidate due to rapidly declining liver function (galactose eliminating capacity 15 µmol.kg -1 ; normal value >30 µmol.kg -1 ) and fatigue. His abnormal liver function and cirrhosis were found two-and-a-half years prior to admission and the diagnosis of primary sclerosing cholangitis was made seven months before surgery. The patient had tuberculosis when he was ten years old. There was moderate thrombocytopenia (platelet count 55.10 9 .l -1 ) and mild coagulopathy (international normalized ratio 1.5) with no history of gastrointestinal bleeding or cardiac disease. He was a heavy smoker but denied alcohol abuse. Preoperative physical examination revealed a blood pressure of 110/70 mmHg and heart rate (HR) of 84 beats.min -1 . The liver and spleen were not enlarged and there was no portal hypertension, ascites or peripheral oedema. The patient was seen by a cardiologist as he had episodes of breathlessness. Chest auscultation was unremarkable. A chest X-ray revealed normal cardiopulmonary outline and clear lung fields and the electrocardiogram showed sinus rhythm. Lung function test was normal (FVC: 4.7 litres, FEV1: 3.9 litres) with moderate to low diffusion capacity (4.6 mmol.min -1 .kPa -1 and normal arterial blood gas report while breathing room air (P a O 2 9.3 kPa, P a CO 2 4.6 kPa). Thus the breathlessness was thought due to anaemia (Hb 5.9 mmol.l -1 [96 g.l -1 ]).
Premedication included oral triazolam 0.25 mg. Anaesthesia was induced with midazolam 10 mg, fentanyl 1 mg, sodium thiopentone 100 mg and pancuronium 8 mg and maintained by continuous infusion of fentanyl at 0.15 µg.kg -1 .min -1 and methohexitone sodium at 4 µg.kg -1 .min -1 plus boluses of fentanyl (0.2-0.5 mg) and pancuronium (2-4 mg) during surgery. A Dräger Cato anaesthetic ventilator was used for IPPV ventilation with 5 cmH 2 O PEEP. Oxygen was mixed with air (no volatile anaesthetics or nitrous oxide were used). A femoral arterial catheter and an oximetry pulmonary artery catheter were placed. A venovenous bypass from the femoral and portal veins to the left internal jugular and cubital veins was used during the anhepatic stage.
Pulmonary hypertension was recognized after induction of anaesthesia with mean pulmonary artery pressure (MPAP) of 44 mmHg, pulmonary capillary wedge pressure (PCWP) of 12 mmHg, central venous pressure (CVP) of 8 mmHg, mean arterial pressure (MAP) of 78 mmHg, HR of 75 beats.min -1 , cardiac output (CO) of 5.7 l.min -1 , pulmonary vascular resistance (PVR) of 449 dyn.s.cm -5 and mixed venous saturation (Sv -O 2 ) of 80%.
We decided to start surgery as cardiac index, PCWP and CVP were normal, indicating no ventricular dysfunction. MPAP increased to a highest value of 60 (90/38) mmHg after the abdominal cavity was opened with MAP of 104 mmHg, PCWP 14 mmHg, CVP 12 mmHg, PVR 478 dyn.s.cm -5 , CO 7.7 l.min -1 and Sv -O 2 84%. Infusion of nitroglycerin from 0.5-1.5 µg.kg -1 .min -1 was tried without response and MPAP stayed at about 55 mmHg. An infusion of prostacyclin (PGI 2 , Flolan, Wellcome, London, England) was then commenced at 4 µg.kg -1 .min -1 and MPAP decreased to 30-45 mmHg with a moderate decrease in MAP (60-70 mmHg) and only slight changes in CO, PCWP and CVP before reperfusion of the grafted liver. MPAP then increased to 51 mmHg, PCWP to 22 mmHg, CVP to 21 mmHg, CO to 10 l.min -1 and PVR decreased to 261 dyn.s.cm -5 with stable MAP (66 mmHg) and Sv -O 2 (83%) after the reperfusion. The infusion rate of PGI 2 was increased to 6 µg.kg -1 .min -1 and MPAP was 40-50 mmHg until the end of surgery.
In the postoperative ICU, MPAP stayed around 50 mmHg with continuous infusion of PGI 2 . Echocardiography showed a hyperdynamic circulation, normal left and right ventricular dimensions and valves, with no cardiac dysfunction or pulmonary embolus. Additional infusion of dobutamine at 2-5 µg.kg -1 .min -1 had no effect on MPAP but there was an initial decrease in MAP. The patient was extubated twenty-one hours after surgery and the MPAP remained around 50 mmHg until the pulmonary artery catheter was removed two days after surgery. The patient's postoperative recovery was uneventful.
DISCUSSION
There are no established criteria for how severe pulmonary hypertension would contraindicate LTX. Mild to moderate pulmonary hypertension does no appear to worsen during LTX or to contribute to mortality, but severe pulmonary hypertension may contraindicate LTX 6 .
Preoperatively there was indication of pulmonary hypertension in this patient in that he had dyspnoea related to pulmonary hypertension rather than to anaemia, as the dyspnoea persisted after the operation when haemoglobin was 8.2 mmol.l -1 (133 g.l -1 ).
Because of the limited exercise tolerance of LTX recipients, clinical tests play a major role in assessing cardiopulmonary risk factors 8 . Echocardiography or radionuclide angiography should be a routine preoperative investigation. Right ventricular catheterization is required when pulmonary hypertension is suspected. In patients with significant pulmonary hypertension and/or with evidence of impaired right ventricular function, vasodilation trial should be performed under monitoring of MPAP and on-line arterial blood pressure. PGI 2 results in the greatest pulmonary vasodilation with the least systemic hypotension 9 . Nitric oxide is as effective as intravenous PGI 2 in decreasing PVR without affecting systemic vascular resistance 10, 11 .
Nitroglycerin and nitroprusside are more likely to cause systemic hypotension, while hydralazine has the least effect on pulmonary vasodilation and results in the largest decrease in systemic vascular resistance 9 . Dobutamine decreases both systemic and pulmonary vascular resistance 12 and improves right ventricular function in the absence of profound hypotension 13 .
If MPAP is unresponsive to vasodilator therapy, the patient should be re-evaluated as a candidate for LTX 4 . Patients may tolerate anaesthesia and surgery if there is a response to vasodilator therapy with a reasonable decrease in MPAP without severe hypotension and with no significant ventricular, especially right side, hypertrophy and dysfunction.
As seen in this case, MPAP was as high as 60 mmHg after the start of surgery and did not respond to nitroglycerin. PGI 2 , decreasing MPAP with only a slight decrease in MAP, is also the drug we routinely use during and after LTX. Dobutamine caused hypotension with no effect on MPAP.
The most critical time during LTX is immediately after reperfusion of the grafted liver when right ventricular strain is expected to occur as preload increases even in the presence of venovenous bypass 8 . In this patient the increase of filling pressure was not critical after the reperfusion. In fact, such changes in filling pressures are common after the reperfusion and patients usually tolerate it well 14 . A venovenous bypass also helps stabilize MPAP 15 which in this case stayed between 28-36 mmHg during period of venovenous bypass. It would be helpful to use transoesophageal echocardiography for monitoring of cardiopulmonary function and as a guide to anaesthesia management throughout the procedure 16 .
Isoflurane has been suggested as a safe anaesthetic for patients with pulmonary hypertension 17 . Barbiturates and opioids have minimal direct effects on MPAP 18 . Most important is to avoid light anaesthesia for patients with pulmonary hypertension. Total intravenous anaesthesia with continuous infusion of fentanyl and methohexitone sodium was successfully used and stable anaesthesia was maintained in this case.
It is concluded that even patients with severe but reversible pulmonary hypertension and with preserved ventricular function may tolerate anaesthesia and LTX surgery under close monitoring and intervention with vasodilator therapy.
